Clinical Trial Update: Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for a mesenchymal stem cell therapy in single ventricle/anomalous left ventricle conditions is ongoing (Phase 1/Phase 2) with unknown st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Canal
• Hypoplastic Left Heart Syndrome

Drugs mentioned

• Mesoblast stem cell therapy

Snippet

Sponsor: Boston Children's Hospital | Conditions: Hypoplastic Left Heart Syndrome, Atrioventricular Canal | Phase 1, Phase 2 | Status: UNKNOWN